Mediation of glutamatergic receptors and nitric oxide on striatal dopamine release evoked by anatoxin-a. An in vivo microdialysis study

European Journal of Pharmacology

Volumn 548, Issue 1-3, 2006, Pages 90-98

  Campos, Francisco ^a   Alfonso, Miguel ^a   Vidal, Lucia ^a   Faro, Lilian R F ^b   Durán, Rafael ^a  

^a UNIVERSITY OF VIGO   (Spain)

^b FEDERAL UNIVERSITY OF PARÁ   (Brazil)

Author keywords

Anatoxin a; Dopamine; Glutamatergic receptor; In vivo microdialysis; Nicotinic receptor; Nitric oxide; Striatum

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; 7 NITROINDAZOLE; AMPA RECEPTOR ANTAGONIST; ANATOXIN A; DIZOCILPINE; DOPAMINE; GLUTAMATE RECEPTOR; IONOTROPIC RECEPTOR; KAINIC ACID RECEPTOR ANTAGONIST; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC ACTIVITY; DRUG EFFECT; DRUG MECHANISM; DRUG SCREENING; EXTRACELLULAR SPACE; FEMALE; IN VIVO STUDY; MICRODIALYSIS; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; RAT; STRIATE CORTEX;

2-AMINO-5-PHOSPHONOVALERATE; 6-CYANO-7-NITROQUINOXALINE-2,3-DIONE; ANIMALS; CORPUS STRIATUM; DIZOCILPINE MALEATE; DOPAMINE; ENZYME INHIBITORS; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; INDAZOLES; MICROCYSTINS; MICRODIALYSIS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, AMPA; RECEPTORS, KAINIC ACID; RECEPTORS, N-METHYL-D-ASPARTATE; TROPANES;

EID: 33748684603     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.07.044     Document Type: Article

References (68)

1. Alfonso M., Duran R., and Arufe M.C. Effect of excitatory amino acids on serum TSH and thyroid hormone levels in freely moving rats. Horm. Res. 54 (2000) 78-83
2. Alfonso M., Duran R., Campos F., Perez-Vences D., Faro L.R., and Arias B. Mechanisms underlying domoic acid-induced DA release from striatum: an in vivo microdialysis study. Neurochem. Res. 28 (2003) 1487-1493
3. Amar M., Thomas P., Johnson C., Lunt G.G., and Wonnacott S. Agonist pharmacology of the neuronal alpha7 nicotinic receptor expressed in Xenopus oocytes. FEBS Lett. 327 (1993) 284-288
4. Arufe M.C., Duran R., Perez-Vences D., and Alfonso M. Endogenous excitatory amino acid neurotransmission regulates thyroid-stimulating hormone and thyroid hormone secretion in conscious freely moving male rats. Endocrine 17 (2002) 193-197
5. Bredt D.S., Glatt C.E., Hwang P.M., Fotuhi M., Dawson T., and Snyder H.S. Nitric oxide synthase protein and mRNA are discretely localized in neuronal populations of the mammalian CNS together with NADPH-diaphorase. Neuron 7 (1991) 615-624
6. Brenman J.E., and Bredt D.S. Synaptic signaling by nitric oxide. Curr. Opin. Neurobiol. 7 (1997) 374-378
7. Campos F., Durán R., Vidal L., Faro L.R.F., and Pallares M. In vivo effects of the anatoxin-a on striatal dopamine release. Neurochem. Res. 31 (2006) 491-501
8. Carlsson M., and Carlsson A. Interaction between glutamatergic and onoaminergic systems within the basal ganglia D{stroke}impli-cations for schizophrenia and Parkinson's disease. Trends Neurosci. 13 (1990) 272-276
9. David D.J., Smith D.A., Adams C.E., and Gerhardt G.A. In vivo electrochemical studies of nicotine-induced release of NO in the rat hippocampus. Society for Neuroscience 28th Annual Meeting, Los Angeles, CA, USA vol. 24 (1998) Part 1, 337 (134.16)
10. Desce J.M., Godeheu G., Galli T., Artaud F., Chèramy A., and Glowinski J. l-glutamate-evoked release of DA from synaptosomes of the rat striatum: involvement of AMPA and NMDA receptors. Neuroscience 47 (1992) 335-339
11. Duran R., Alfonso M., and Arias B. Determination of biogenic amines in rat brain dialysates by high performance liquid chromatography. J. Liq. Chromotogr. Relat. Technol. 21 (1998) 2799-2811
12. Faro L.R., do Nascimento J.L., Alfonso M., and Duran R. Protection of methylmercury effects on the in vivo dopamine release by NMDA receptor antagonists and nitric oxide synthase inhibitors. Neuropharmacology 42 (2002) 612-618
13. Gago-Martinez A., Rellan S., Campos F., Alfonso M., and Durán R. HPLC determination of anatoxin-a. An application for the evaluation of this diffusion rate through the microdialysis probe. The 117th AOAC International Annual Meeting and Exposition. Atlanta (2003)
14. Garthwaite J., Charles S.L., and Chess-Williams R. Endotheliumderived relaxing factor release on activation of NMDA receptors suggests role as intracellular messenger in the brain. Nature 336 (1988) 385-388
15. Garthwaite J., and Boulton C.L. Nitric oxide signaling in the central nervous system. Annu. Rev. Physiol. 57 (1995) 683-706
16. Gray R., Rajan A.S., Radcliffe K.A., Yakehiro M., and Dani J.A. Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature 383 (1996) 713-716
17. Greenamyre J.T., Olson J.M.M., Penney J.B., and Young A.B. Autoradiographic characterization of N-methyl-d-aspartate-, quisqualate- and kainate-sensitive glutamate binding sites. J. Pharmacol. Exp. Ther. 223 (1995) 254-263
18. Hamada M., Higashi H., Nairn A.C., Greengard P., and Nishi A. Differential regulation of dopamine D1 and D2 signaling by nicotine in neostriatal neurons. J. Neurochem. 90 (2004) 1094-1103
19. Hanbauer I., Wink D., Osawa Y., Edelman G.M., and Gally J.A. Role of nitric oxide in NMDA-evoked release of [3H]-dopamine from striatal slices. NeuroReport 3 (1992) 409-412
20. Hernandez L.F., Segovia G., and Mora F. Effects of activation of NMDA and AMPA glutamate receptors on the extracellular concentrations of dopamine, acetylcholine, and GABA in striatum of the awake rat: a microdialysis study. Neurochem. Res. 28 (2003) 1819-1827
21. Iravani M.M., Millar J., and Kruk Z.L. Differential release of dopamine by nitric oxide in subregions of rat caudate putamen slices. J. Neurochem. 71 (1998) 1969-1977
22. Kaiser S., and Wonnacott S. a-Bungarotoxin-sensitive nicotinic receptors indirectly modulate [3H]dopamine release in rat striatal slices via glutamate release. Mol. Pharmacol. 58 (2000) 312-318
23. Keefe K.A., Zigmond M.J., and Abercrombie E.D. Extracellular dopamine in striatum: influence of nerve impulse activity in medial forebrain bundle and local glutamatergic input. Neuroscience 47 (1992) 325-332
24. Kendrick K.M., Guevara-Guzman R., De la Riva C., Christensen J., Ostergaard K., and Emson P.C. NMDA and kainate-evoked release of nitric oxide and classical ransmitters in the rat striatum: in vivo evidence that nitric oxide may play a neuroprotective role. Eur. J. Neurosci. 8 (1996) 2619-2634
25. Kiss J.P. Role of nitric oxide in the regulation of monoaminergic neurotransmission. Brain Res. Bull. 52 (2000) 459-466
26. Kiss J.P., Hennings E.C., Zsilla G., and Vizi E.S. A possible role of nitric oxide in the regulation of dopamine transporter function in the striatum. Neurochem. Int. 34 (1999) 345-350
27. Kiss J.P., Zsilla G., and Vizi E.S. Inhibitory effect of nitric oxide on dopamine transporters: interneuronal communication without receptors. Neurochem. Int. 45 (2004) 485-489
28. Lonart G., and Johnson K.M. Inhibitory effects of nitric oxide on the uptake of [3H]dopamine and [3H]glutamate by striatal synaptosomes. J. Neurochem. 63 (1994) 2108-2117
29. Lonart G., Cassels K.L., and Johnson K.M. Nitric oxide induces calcium-dependent [3H]dopamine release from striatal slices. J. Neurosci. Res. 35 (1993) 192-198
30. Lorrain D.S., and Hull E.M. Nitric oxide increases dopamine and serotonin release in the medial preoptic area. NeuroReport 5 (1993) 87-89
31. Macallan D.R.E., Lunt G.G., Wonnacott S., Swanson K.L., Rapoport H., and Albuquerque E.X. Methyllycaconitine and (+)-anatoxin-a differentiate between nicotinic receptors in vertebrate and invertebrate nervous systems. FEBS Lett. 226 (1988) 357-363
32. Mansvelder H.D., and McGehee D.S. Long-term potentiation of excitatory inputs to brain reward areas by nicotine. Neuron 27 (2000) 349-357
33. * nicotinic cholinergic receptors are localized on human and rat brain glutamatergic axon terminals. J. Neurochem. 80 (2002) 1071-1078
34. Nomikos G.G., Schilstrom B., Hildebrand B.E., Panagis G., Grenhoff J., and Svensson T.H. Role of alpha7 nicotinic receptors in nicotine dependence and implications for psychiatric illness. Behav. Brain Res. 113 (2000) 97-103
35. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1987), Academic, Sydney
36. Pittaluga A., and Raiteri M. N-Methyl-d-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. I. Location on axon terminals and pharmacological characterization. J. Pharmacol. Exp. Ther. 260 (1992) 232-237
37. Pittaluga A., Pattarini R., Feligioni M., and Raiteri M. NMDA receptors mediating hippocampal noradrenaline and striatal dopamine release display differential sensitivity to quinolinic acid, the HIV-1 envelope protein gp120, external pH and PKC inhibition. J. Neurochem. 76 (2001) 139-148
38. Pogun S., Brenman M.H., and Kuhar M.J. Nitric oxide inhibits [3H]dopamine uptake. Brain Res. 641 (1994) 83-91
39. Pogun S., Demirgoren S., Taskiran D., Kanit L., Yilmaz O., Koylu E.O., Balkan B., and London E.D. Nicotine modulates nitric oxide in rat brain. Eur. Neuropsychopharmacol. 10 (2000) 463-472
40. Quintela B.A., Duran R., and Alfonso M. Mediation of ionotropic glutamate receptors in domoic acid-induced striatal dopamine release in rats. Eur. J. Pharmacol. 401 (2000) 173-177
41. Risso F., Parodi M., Grlli M., Molfino F., Raiteri M., and Marchi M. Chronic nicotine causes functional upregulation of ionotropic glutamate receptors mediating hippocampal noradrenaline and striatal dopamine release. Neurochem. Int. 44 (2004) 293-301
42. Roberts P.J., and Anderson S.D. Stimulatory effect of l-glutamate and related amino acids on [3H]dopamine release from rat striatum: an in vitro model for glutamate actions. J. Neurochem. 32 (1979) 1539-1545
43. 2+ channels. Brain Res. 1047 (2005) 18-29
44. Schilstrom B., Nomikos G.G., Nisell M., Hertel P., and Svensson T.H. N-methyl-d-aspartate receptor antagonism in the ventral tegmental area diminishes the systemic nicotine-induced dopamine release in the nucleus accumbens. Neuroscience 82 (1998) 781-789
45. * nicotinic receptors in nicotine stimulated increases of extracellular levels of glutamate and aspartate in the ventral tegmental area. Synapse 38 (2000) 375-383
46. Schilstrom B., Rawal N., Mameli-Engvall M., Nomikos G.G., and Svensson T.H. Dual effects of nicotine on dopamine neurons mediated by different nicotinic subtypes. Int. J. Neuropsychopharmacol. 6 (2003) 1-11
47. Schilstrom B., Mameli-Engvall M., Rawal N., Grillner P., Jardemark K., and Svensson T.H. Nitric oxide is involved in nicotine-induced burst firing of rat ventral tegmental area dopamine neurons. Neuroscience 125 (2004) 957-964
48. Schuman E.M., and Madison D.V. Nitric oxide and synaptic function. Annu. Rev. Neurosci. 17 (1994) 153-183
49. Segovia G., Del Arco A., and Mora F. Endogenous glutamate increases extracellular concentrations of dopamine, GABA, and taurine through NMDA and AMPA/kainate receptors in striatum of the freely moving rat: a microdialysis study. J. Neurochem. 69 (1997) 1476-1483
50. * subtype in the modulation of dopamine release from rat striatal synaptosomes. J. Neurosci. 20 (2000) 2783-2791
51. Smith D.A., Hoffman A.F., David D.J., Adams C.E., and Gerhardt G.A. Nicotine-evoked nitric oxide release in the rat hippocampal slice. Neurosci. Lett. 255 (1998) 127-130
52. Smolders I., Sarre S., Vanhaesendonck C., Ebinger G., and Michotte Y. Extracellular striatal dopamine and glutamate after decortication and kainate receptor stimulation, as measured by microdialysis. J. Neurochem. 66 (1996) 2373-2380
53. 2+ channels involved in nicotinic receptor-mediated [3H]DA release from rat striatal synaptosomes. J. Neurochem. 67 (1996) 163-170
54. Soliakov L., and Wonnacott S. Involvement of protein kinase C in the presynaptic nicotinic modulation of [(3)H]-dopamine release from rat striatal synaptosomes. Br. J. Pharmacol. 132 (2001) 785-791
55. Soliakov L., Gallagher T., and Wonnacott S. AnTx-evoked [3H]DA release from rat striatal synaptosomes. Neuropharmacology 34 (1995) 1535-1541
56. Spivak C.E., Witkop B., and Albuquerque E.X. Anatoxin-a: a novel, potent agonist at the nicotinic receptor. Mol. Pharmacol. 18 (1980) 384-394
57. Strasser A., McCarron R.M., Ishii H., Stanimirovic D., and Spatz M. l-arginine induces dopamine release from the striatum in vivo. NeuroReport 5 (1994) 2298-2300
58. Swanson K.L., Allen C.N., Aronstam R.S., Rapoport H., and Albuquerque E.X. Molecular mechanisms of the potent and stereospecific nicotinic receptor agonist (+)-anatoxin-a. Mol. Pharmacol. 29 (1986) 250-257
59. Tarazi F.I., Campbell A., Yeghiayan S.K., and Baldessarini R.J. Localization of ionotropic glutamate receptors in caudate-putamen and nucleus accumbens septi of rat brain: Comparison of NMDA, AMPA, and kainate receptors. Synapse 30 (1998) 227-235
60. Thomas P., Stephens M., Wilkie G., Amar M., Lunt G.G., Whiting P., Gallagher T., Pereira E., Alkondon M., Albuquerque E.X., and Wonnacott S. (+) anatoxin-a is a potent agonist at neuronal nicotinic acetylcholine receptors. J. Neurochem. 60 (1993) 2308-2311
61. Toth E., Sershen H., Hashim A., Vizi E.S., and Lajtha A. Effect of nicotine on extracellular levels of neurotransmitters assessed by microdialysis in various brain regions: role of glutamic acid. Neurochem. Res. 17 (1992) 265-271
62. Uzbay I.T., and Oglesby M.W. Nitric oxide and substance dependence. Neurosci. Biobehav. Rev. 25 (2001) 43-52
63. Vleeming W., Rambali B., and Opperhuizen A. The role of nitric oxide in cigarette smoking and nicotine addiction. Nicotine Tob. Res. 4 (2002) 341-348
64. Wang J.K.T. Presynaptic glutamate receptors modulate dopamine release from striatal synaptosomes. J. Neurochem. 57 (1991) 819-822
65. West A.R., and Galloway M.P. Intrastriatal infusion of (2)-S-nitroso-N-acetylpenicillamine releases vesicular dopamine via an ionotropic glutamate receptor-mediated mechanism: an in vivo microdialysis study in chloral hydrate-anesthetized rats. J. Neurochem. 66 (1996) 1971-1980
66. Wonnacott S. Presynaptic nicotinic ACh receptors. Trends Neurosci. 20 (1997) 92-98
67. Wonnacott S., Kaiser S., Mogg A., Soliakov L., and Jones I.W. Presynaptic nicotinic receptors modulating dopamine release in the rat striatum. Eur. J. Pharmacol. 393 (2000) 51-58
68. Zhu X.Z., and Luo L.G. Effect of nitroprusside (nitric oxide) on endogenous dopamine release from rat striatal slices. J. Neurochem. 59 (1992) 932-935